Page 3 of Cipla

Cipla, appointment, vice chairman, board members, healthcare sector, pharma

Cipla EU to invest an additional 3 million euros in Ethris

mRNA-based medicines have a huge potential in several indications as infectious disease vaccines, therapeutic cancer vaccines, and protein replacement therapies.

June 18, 2024 16:45 IST

Cipla gets USFDA nod for its generic formulation to treat pancreatic cancer

According to IQVIA (IMS Health), Somatuline Depot (Lanreotide) had US sales of approximately $898M for the 12 months ending March…

May 22, 2024 11:06 IST

Cipla announces additional investment of Rs 26 crore in Achira Labs; To advance in PoC Diagnostics segment

According to the completion of the first tranche of investment, Cipla shall hold 27.27 percent of the total voting rights…

May 16, 2024 10:30 IST

Cipla’s promoters offload 2.53% stake through a block deal worth Rs 2,750 crore

The promoters – Shirin Hamied, Samina Hamied, Rumana Hamied and Okasa Pharma – offloaded 20.45 million shares through the block…

Updated: May 16, 2024 07:12 IST

Promoters may offload 2.53% Cipla stake worth Rs 2,637 crore

The promoters — Shirin Hamied, Samina Hamied, Rumana Hamied and Okasa Pharma — would be offloading about 20.45 million shares,…

May 15, 2024 14:25 IST

Cipla Health strengthens its play in beauty and personal care

This strategic move is aligned with Cipla’s focus on enhancing its consumer healthcare and wellness portfolio, it claimed.

April 16, 2024 10:30 IST

Cipla Q3 profit, Cipla Q3, Cipla Q3 news, Cipla news, industry news

Cipla to witness surge in profit due to growth in its complex respiratory portfolio: Report

Cipla’s India business has reported substantial traction, with a 60 percent contribution from the Chronics portfolio.

April 3, 2024 13:40 IST

Sanofi India, Cipla, partnership, distribution, CNS portfolio, anti-epileptic medication, production, manufacturing, healthcare

Sanofi, Cipla enters into exclusive distribution partnership to expand reach of CNS portfolio in India

While Sanofi India will continue to own, import, and manufacture its complete range of CNS products across plants in India…

March 27, 2024 09:33 IST

Cipla gets approval to introduce antibiotic injection to treat UTIs in India

Cipla USA, a subsidiary of Cipla, holds the patent for plazomicin sulfate, an intravenous aminoglycoside administered once daily.

February 27, 2024 10:23 IST

Cipla, Cipla EU, Cipla EU Limited, Cipla News, Cell Therapy, healthcare news, pharma news,

Cipla announces joint venture for global development and commercialisation of innovative cell therapy products

This marks the second joint venture between Cipla and Kemwell Biopharma, following the incorporation of Aspergen Inc., USA in 2022…

January 9, 2024 12:13 IST

Cipla, GoApptiv, stake sale, healthcare news, pharma news,

Cipla announces further investment in GoApptiv; To hold over 22 percent stake in the digital tech company

The current investment round will further solidify the partnership with Goapptiv in addressing healthcare disparities in underserved regions of India,…

December 15, 2023 14:16 IST

Stocks to Watch: BPCL, Tata Motors, Adani Green Energy, Cochin Shipyard, Cipla, Paytm

GIFT Nifty indicated a flat opening for Indian equity indices BSE Sensex and NSE Nifty 50. Here’s a look at…

December 11, 2023 07:13 IST

Asthma, Asthma in India, Cipla, Cipla respiratory diseases, cipla respiratory disease segment, healthcare news, pharma news,

Widespread awareness about asthma and promoting better understanding of inhalation therapy crucial: Achin Gupta, CEO – One India Business, Cipla Ltd.

A 2022 study has revealed that stigma associated with asthma is preventing patients from getting the right treatment in India.

December 8, 2023 08:00 IST

Pharmaceutical, Cipla, Q2FY24 results, profit, revenue, EBITDA, trade generics businesses, prescription, OTC segment

Cipla Q2 Results: Profit surges 43.3% to Rs 1130.91 crore, revenue up 14.6% on-year, beats estimates

Cipla posted revenue from operations at Rs 6,678.15 crore, up 14.6 per cent as against Rs 5,828.54 crore during the…

October 27, 2023 15:31 IST

Cipla launches drone-based delivery services for distribution of medicines in Himachal Pradesh

Cipla is the first among large Indian pharma companies to adopt drone-based deliveries to facilitate expedited supply to stockists in…

September 26, 2023 17:33 IST

Generic medicines, biosimilars, Cipla, Sun Pharma, healthcare news, pharma news,

Generic and biosimilar products are still out of reach for many patients in LMICs, reveals new report

Of the medicines classed as “essential” by the World Health Organization (WHO), 90 percent are off patent, including treatments for…

September 26, 2023 15:06 IST

Torrent Pharmaceuticals, Torrent Pharma, Cipla, healthcare news, pharma news,

Torrent in talks with Apollo to borrow up to $1 billion for Cipla bid: Report

Cipla, which has a market cap of some $12 billion, is known for making the anti-allergy drug Cetirizine and generic…

September 19, 2023 15:07 IST

Related News

Employee quits google job, Google Manager Quits Rs 3.4 Crore Job

Google manager quits Rs 3.4 crore job, says ‘the work was pleasant, but…’

Tata Capital IPO updates 2025, Tata Capital IPO live allotment status

LIVE: Tata Capital IPO allotment to be finalised today, GMP nears issue price – Step by step guide to check status online

Who is Alexandr Wang? The 28-year-old hired by Mark Zuckerberg for $14 billion to head Meta’s Superintelligence Labs

Aadhaar Card update October 2025: Here’s how to change name, address, date of birth and phone number online in simple steps

Canada Open work permit, Canada Open work permit policy, Open work permit requirements, Canada temporary resident, Canada permanent resident pathway

Canada open work permit deadline extended till December end

States told to expedite crop loss surveys for Fasal Bima

Economy31 min ago

The agriculture ministry has instructed states to conduct mid-season crop loss assessment under PMFBY to provide timely compensation to farmers affected by heavy rainfall. States are also advised to monitor progress and release premium subsidy to insurance companies. Despite obstacles, over Rs 1.86 lakh crore has been paid to farmers under PMFBY since 2016, with a rise in participation.

View all shorts